Australia markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.30+0.72 (+2.61%)
At close: 04:00PM EDT
28.35 0.00 (0.00%)
After hours: 05:29PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9999
Avg. Estimate-0.99-0.85-3.33-3.16
Low estimate-1.42-1.01-3.8-4.14
High estimate-0.72-0.67-2.87-2.35
Year ago EPS-1.42-0.82-3.69-3.33
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7778
Avg. EstimateN/AN/AN/A13.04M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A53.64M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.98-0.97-0.92-0.96
Actual EPS-1.42-0.82-0.91-0.54
Difference-0.440.150.010.42
Surprise %-44.90%15.50%1.10%43.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.99-0.85-3.33-3.16
7 days ago-0.98-0.84-3.34-3.09
30 days ago-0.95-0.94-3.74-3.34
60 days ago-0.96-0.89-3.91-3.71
90 days ago-0.93-0.94-4.11-3.89
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A111
Up last 30 days1664
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/AN/A
Growth estimatesCGEMIndustrySector(s)S&P 500
Current qtr.30.30%N/AN/AN/A
Next qtr.-3.70%N/AN/AN/A
Current year9.80%N/AN/AN/A
Next year5.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A